Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Leukemia & Lymphoma Society’s Dare to Dream project helps pediatric cancer patients like Cayden, who received CAR-T therapy.
Loui J. DeGennaro, PhD, served 18 years at LLS, a nonprofit funder of blood cancer research and clinical trials.
Lawmakers were asked to support the NIH Clinical Trials Diversity Act and kids’ access to cancer care.
Read the first day message from E. Anders Kolb, MD, the new president and CEO of The Leukemia & Lymphoma Society (LLS).
University of Colorado’s Adam Green, MD, aims to use research findings to help address disparities in childhood cancers.
What’s more, receiving SNAP benefits was not enough to address food insecurity for many families of children with leukemia, a study found.
The unique study analyzed infants and their mothers.
New studies offer evidence that an unexpected virus plays a role—but it needs a helper.
Azacitidine (Vidaza) was approved for pediatric patients with newly diagnosed juvenile myelomonocytic leukemia (JMML).
Humans and companion animals get similar cancers, so clinical trials in dogs can lead to research in humans—and vice versa.
The approval makes this the first single-pill regimen containing dolutegravir available in a water-dispersible formulation.
As sexually transmitted infections surge nationwide, a California law—the first of its kind—requires health insurance to cover home tests.
A high-quality trial should improve access to dolutegravir for children worldwide.
The Food and Drug Administration approved the single-pill treatment for children weighing at least 30 pounds.
The proceeds will benefit St. Jude Children’s Research Hospital in Memphis.
New guidelines from the Department of Health and Human Services went into effect immediately.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.